Genmab A (GMAB) Restructuring Costs (2024 - 2026)
Genmab A's Restructuring Costs was -$32 million in the quarter ended Jun 30, 2026.
Genmab A (GMAB) Restructuring Costs (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Genmab A's Restructuring Costs was -$120 million through Jun 30, 2026; for the year ended Dec 31, 2025, it came in at -$185 million.
- In earlier years, Restructuring Costs was -$43 million in the year ended Dec 31, 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.90 Bn | 1,102.48 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.46 Bn | 534.99 Bn | 17.26 Bn |
| 3 | AbbVie | 501.26 Bn | 474.37 Bn | 12.70 Bn |
| 4 | Merck | 367.00 Bn | 321.38 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.91 Bn | 261.90 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn |
| 7 | Amgen | 235.82 Bn | 191.22 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.63 Bn | 164.82 Bn | 6.22 Bn |
| 9 | Pfizer | 169.35 Bn | 115.99 Bn | 10.94 Bn |
| 10 | Genmab A | 2.55 Bn | -2.82 Bn | 1.07 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -32.00 Mn |
| Mar 31, 2026 | -45.00 Mn |
| Dec 31, 2024 | -43.00 Mn |
| Sep 30, 2024 | -3.00 Mn |
| Jun 30, 2024 | -25.00 Mn |
Genmab A Restructuring Costs API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=restructuring-costs&ticker=GMAB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "restructuring-costs", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=restructuring-costs&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();